Creative Commons Attribution: Flickr User Conference Basics
David F. Dalvey - Mr. Dalvey has over thirty collective years of corporate board experience, with over twelve of those years attributed to public, SEC regulated companies. Mr. Dalvey has significant experience as a board director/advisor to several publically-traded companies including Navarre Corporation (Nasdaq: NAVR), NatureVision (Nasdaq: NRVN), August Technology (Nasdaq: AUGT), Health Fitness Corporation (Nasdaq: HFIT) and currently serves as an independent Director and Audit Committee member of The Blue Rock Market Neutral Fund LP, an SEC registered hedge fund. Mr. Dalvey also served as a director to several private businesses including Definity Health Inc., AppTec Laboratory Services Inc., chf Solutions Inc., Gentra Systems Inc., and Agiliti, Inc. Mr. Dalvey’s director qualifications include his experience advising and building growth businesses and investment portfolios, his understanding of corporate finance, merger, acquisition and divestiture transactions, and his experience with and understanding of capital markets and the management of liquidity transactions for portfolio company investments. Mr. Dalvey has significant investment banking and equity investment experience with two venture capital firms, two national investment banks and two national commercial banking institutions working primarily with growth-oriented technology businesses. Mr. Dalvey is chair of the Governance and Nominating Committee.
Kent O. Lillemoe - Mr. Lillemoe has extensive senior level executive experience, serving from January 2006 through April 2009 as chief financial officer of MinuteClinic, Inc., a “retail healthcare” company that integrates affordable healthcare solutions into consumer lifestyles. Previously, he served as chief financial officer of Envoy Medical Corporation, a start-up medical technology company focused on developing a fully-implantable device for the hearing impaired. Earlier (June 2000 through Jan. 2003), he served as founder, director and chief operating officer of Avante Optics Corporation, a start-up technology company focused on developing high-speed processes and equipment for manufacturing optical components. Mr. Lillemoe currently serves on corporate boards of directors, including Exos Corporation, Mobi, LLC and Wireless Ronin Technologies, Inc. He also serves as an advisor to Vast Enterprises and Finnegans, Inc. Mr. Lillemoe is chair of the Audit Committee.
Board of Directors
Board Members
Creative Commons Attribution: Flickr User Conference Basics
David F. Dalvey - Mr. Dalvey has over thirty collective years of corporate board experience, with over twelve of those years attributed to public, SEC regulated companies. Mr. Dalvey has significant experience as a board director/advisor to several publically-traded companies including Navarre Corporation (Nasdaq: NAVR), NatureVision (Nasdaq: NRVN), August Technology (Nasdaq: AUGT), Health Fitness Corporation (Nasdaq: HFIT) and currently serves as an independent Director and Audit Committee member of The Blue Rock Market Neutral Fund LP, an SEC registered hedge fund. Mr. Dalvey also served as a director to several private businesses including Definity Health Inc., AppTec Laboratory Services Inc., chf Solutions Inc., Gentra Systems Inc., and Agiliti, Inc. Mr. Dalvey’s director qualifications include his experience advising and building growth businesses and investment portfolios, his understanding of corporate finance, merger, acquisition and divestiture transactions, and his experience with and understanding of capital markets and the management of liquidity transactions for portfolio company investments. Mr. Dalvey has significant investment banking and equity investment experience with two venture capital firms, two national investment banks and two national commercial banking institutions working primarily with growth-oriented technology businesses. Mr. Dalvey is chair of the Governance and Nominating Committee.
Kent O. Lillemoe - Mr. Lillemoe has extensive senior level executive experience, serving from January 2006 through April 2009 as chief financial officer of MinuteClinic, Inc., a “retail healthcare” company that integrates affordable healthcare solutions into consumer lifestyles. Previously, he served as chief financial officer of Envoy Medical Corporation, a start-up medical technology company focused on developing a fully-implantable device for the hearing impaired. Earlier (June 2000 through Jan. 2003), he served as founder, director and chief operating officer of Avante Optics Corporation, a start-up technology company focused on developing high-speed processes and equipment for manufacturing optical components. Mr. Lillemoe currently serves on corporate boards of directors, including Exos Corporation, Mobi, LLC and Wireless Ronin Technologies, Inc. He also serves as an advisor to Vast Enterprises and Finnegans, Inc. Mr. Lillemoe is chair of the Audit Committee.